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Loss of the Acyl-CoA Binding Protein (Acbp) Results
in Fatty Acid Metabolism Abnormalities in Mouse
Hair and Skin
Lance Lee1, C. Anthony DeBono2, Dean R. Campagna1, David C. Young2, D. Branch Moody2 and
Mark D. Fleming1
Proper fatty acid metabolism is critical for hair and skin development and maintenance. The acyl-CoA binding
protein (Acbp) is a widely expressed protein that binds long-chain fatty acyl-CoA esters and plays a role in fatty
acyl-CoA transport and pool formation. However, loss of function of Acbp in the whole animal has not been
investigated. Here, we show that deletion of Acbp in mouse results in sebocyte hyperplasia and sparse, matted
hair with a greasy appearance. Consistent with these gross abnormalities, Acbp is highly expressed in the
pilosebaceous units of mouse skin as determined by Northern analysis and in situ hybridization. Loss of Acbp
also results in fatty acid metabolism abnormalities, with hair lipid profiles showing altered levels of
triacylglycerols and nearly co-migrating lipids. These data suggest that Acbp plays a role in triacylglycerol
biosynthesis, and that regulation of this process is important for proper hair and skin development and
maintenance in the mouse.
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INTRODUCTION
Long-chain fatty acyl-CoA esters function as substrates and
intermediates in lipid biosynthesis and catabolism and also
play a role in regulating carbohydrate metabolism, protein
sorting, gene expression, and signal transduction (Faergeman
and Knudsen, 1997; Knudsen et al., 2000). Homeostatic
control of these molecules is, therefore, essential for
numerous cellular functions.
The acyl-CoA binding protein (Acbp), which was also
identified as the diazepam-binding inhibitor (Mocchetti and
Santi, 1991), is a 10 kDa, cytoplasmic protein that binds
medium- and long-chain fatty acyl-CoA esters and plays a
role in fatty acid metabolism (Knudsen et al., 1999). Acbp is
found in eucaryotes ranging from yeast to mammals (Knudsen
et al., 1999). Although testis- and brain-specific isoforms
have been identified, most tissues express a common form
(Knudsen et al., 1999).
Several studies have indicated that Acbp contributes to
intracellular acyl-CoA transport and pool formation. In vitro,
Acbp binds C14–C22 acyl-CoA esters with high affinity, but
does not bind free fatty acids, acyl carnitines, or cholesterol
(Rasmussen et al., 1990; Rosendal et al., 1993). Acbp protects
long-chain acyl-CoA esters from hydrolysis by microsomal
hydrolases and can donate acyl-CoA for mitochondrial
oxidation and microsomal glycerolipid synthesis (Rasmussen
et al., 1993, 1994). Specifically, in vitro, binding of long-
chain fatty acyl-CoAs to Acbp inhibits their incorporation into
triacylglycerols in microsomal membranes, whereas incor-
poration into phospholipids is relatively unaffected, suggest-
ing that Acbp preferentially donates fatty acyl-CoAs for
neutral glycerolipid synthesis (Rasmussen et al., 1993).
Overexpression of the bovine or Saccharomyces cerevisiae
orthologs in yeast results in an increase in the intracellular
acyl-CoA ester pool size (Mandrup et al., 1993; Schjerling
et al., 1996). Conversely, disruption of the yeast ortholog
results in an accumulation of long-chain acyl-CoA esters,
particularly octadecanoyl-CoA (C18:0), with no change in
fatty acyl-CoA synthesis (Schjerling et al., 1996). Addition of
Acbp causes a dramatic decrease in the average chain length
of acyl-CoA esters, suggesting that Acbp may function in the
transport of acyl-CoA esters from the site of synthesis to the
intracellular pools where they are available for enzymes
involved in their processing and catabolism. Overall, these
studies indicate that Acbp plays a role in the availability of
long-chain fatty acyl-CoA esters for a variety of biochemical
processes.
To date, most Acbp functional studies have been
performed in vitro or in yeast. Reduction of Acbp in a variety
of human cell lines by small interference RNA results in cell
lethality, suggesting that Acbp performs an essential function
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(Faergeman and Knudsen, 2002). Recently, transgenic over-
expression of Acbp in mice was shown to result in an
increase in liver long-chain fatty acyl-CoA pool size,
particularly levels of saturated and polyunsaturated fatty
acyl-CoAs (Huang et al., 2005). However, loss of function has
not been investigated in vivo.
In this paper, we describe hair and skin abnormalities in
mice homozygous for the nm1054 mutation, which was
previously described as a recessive, pleiotropic mutation
caused by an approximately 400 kb deletion on chromosome
1 (Ohgami et al., 2005a, b). Here, we characterize hair and
skin abnormalities in nm1054 deletion mutants and show that
these phenotypes result from a loss of Acbp and are related to
a defect in cutaneous fatty acid metabolism.
RESULTS
Cutaneous abnormalities in nm1054 mice
As they develop their adult coat, B6129F1 mice homozygous
for the nm1054 deletion have sparse, reddish, matted hair
with a greasy appearance (Figure 1a–c). To determine the
nature of the cutaneous abnormality, we examined the
histological appearance of adult skin from a variety of
locations. The epidermis and dermis appear normal in
nm1054 mutants, and there is a normal distribution of
pilosebaceous units (PSUs), which are comprised of hair
follicles and sebocytes. However, consistent with the
greasy appearance of nm1054 hair, there is an increased
number of sebocytes associated with most PSUs from
skin of the lower thorax (Figure 2a and b) and the nose
(Figure 2c and d) of nm1054 deletion homozygotes. No
differences were observed in the skin from the paws (Figure
2e and f) or the tail (Figure 2g and h), or in juvenile skin (data
not shown).
Transgenic rescue of the cutaneous phenotype
A bacterial artificial chromosome (BAC) contig of the
nm1054 deletion interval was developed previously (Ohgami
et al., 2005b). Two transgenic lines derived from CITB BAC
clone 486B9 (Kim et al., 1996) rescue the gross and
microscopic cutaneous phenotypes but not the other
nm1054 phenotypes (Figure 3a–c; Ohgami et al., 2005a).
Based on sequence analysis, two genes are predicted to be
present on BAC 486B9: Acbp and a novel gene, which will
be referred to by its GenBank accession number BAB29121
(Carninci and Hayashizaki, 1999). The appearance of the hair
and the sebocyte hyperplasia in deletion mutants, combined
with the documented role of Acbp in fatty acid metabolism,
suggested that Acbp was a strong candidate for the nm1054
cutaneous phenotype.
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Figure 1. The nm1054 hair phenotype. (a) Appearance of 8-week, male,
B6129F1 wild-type (left) and nm1054 deletion homozygous (right) mice. Note
the matted, greasy appearance of the nm1054 fur. (b) Hair from the back of an
8-week, male, B6129F1 nm1054 heterozygote. Original magnification  10.
(c) Hair from the back of an 8-week, male, B6129F1 nm1054 deletion
homozygote. The mutant hair appears more reddish in color. Original
magnification  10.
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Figure 2. Histological analysis of skin from 8-week, male, wild-type and
nm1054 mice. (a, b) Sections of (a) wild-type and (b) nm1054 skin from the
lower thorax. (c, d) Sections of (c) wild-type and (d) nm1054 skin from the
nose. (e, f) Sections of (e) wild-type and (f) nm1054 skin from the paws.
(g, h) Sections of (g) wild-type and (h) nm1054 skin from the tail. Arrowheads
indicate PSUs. Original magnification  10. All sections are stained with
hematoxylin and eosin.
www.jidonline.org 17
L Lee et al.
Acbp and Cutaneous Fatty Acid Metabolism in Mouse
The BAB29121 gene has five exons and encodes a novel,
121 amino-acid predicted protein with no identifiable
domains and no homology to any known proteins. Expressed
sequence tags have been sequenced from thymus, uterus,
mammary gland, lymph node, and brain, and there are
predicted orthologs in species ranging from yeast to humans.
BAB29121 is expressed in wild-type mouse thymus but not in
nm1054 or BAC 486B9 transgenic nm1054 animals (Figure
3d), suggesting that the gene or regulatory elements may
extend beyond the limits of the BAC or are disrupted by
insertion of circularized BAC DNA. Alternatively, the gene
could be silenced owing to a positional insertion effect. Lack
of BAB29121 expression in BAC 486B9 transgenic nm1054
animals further suggests that the cutaneous phenotypes result
solely from a loss of Acbp.
Expression of Acbp
Acbp expression was previously documented in murine
brain, liver, and kidney by Northern analysis (Owens et al.,
1989). Expression of the rat and bovine orthologs has also
been reported in many tissues (Mocchetti et al., 1986;
Mikkelsen and Knudsen, 1987; Bovolin et al., 1990). A
murine Northern blot shows strong Acbp expression in most
tissues, with the highest expression in liver and skin and
lower levels in spleen, muscle, and thymus (Figure 4a).
Because of the abnormalities in nm1054 skin and the high
level of Acbp expression in skin by Northern analysis, we
performed in situ hybridization for Acbp mRNA. Acbp
expression was detected in the epidermis, hair follicles, and
sebocytes of skin from the lower thorax (Figure 4b). This
finding is consistent with ACBP protein expression in the
epidermis and sebaceous glands of human skin (Alho et al.,
1993). Similar epidermal and PSU expression was detected in
skin from the nose (Figure 4d). No expression was detected in
nm1054 skin (Figure 4c and e). Taken together with the
function of Acbp in lipid metabolism and the absence of
BAB29121 expression in BAC transgenic nm1054 mutants,
these data provide further evidence that Acbp is responsible
for the nm1054 hair and skin abnormalities.
Lipid analysis in nm1054 mice
As in vitro studies had previously implicated Acbp in binding
and metabolism of acyl-CoA esters, as well as facilitating
production of various acylated lipids, we carried out global
lipid analyses in several tissues from wild-type, nm1054, and
BAC 486B9 transgenic nm1054 mice. We used multiple
methods to develop complete profiles for lipids from liver,
skin, and hair. Although we detected no differences in the
profiles of liver or skin lipids (Figures S1 and S2; and data not
shown), distinctive differences were observed in the profile of
lipids extracted from hair.
Silica thin-layer chromatography (TLC) and HPLC – mass
spectrometry demonstrated no significant differences in the
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Figure 3. BAC transgenic rescue of the nm1054 cutaneous abnormality.
(a–c) Histology of (a) wild-type, (b) nm1054, and (c) BAC 486B9 transgenic
nm1054 skin from the lower thorax. Original magnification  20. All sections
are stained with hematoxylin and eosin. (d) Reverse transcription-PCR of
BAB29121 from mouse thymus RNA. b-Actin was used as a loading control.
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Figure 4. Expression of mouse Acbp. (a) Northern analysis of Acbp mRNA
expression in brain (br), heart (he), kidney (ki), liver (li), lung (lu), muscle (mu),
skin (sk), small intestine (si), spleen (sp), stomach (st), testis (te), and thymus
(th). (b, c) In situ hybridization analysis of Acbp expression in 8-week, male,
(b) wild-type and (c) nm1054 mouse skin from the lower thorax. (d, e) In situ
hybridization analysis of Acbp expression in 8-week, male, (d) wild-type
and (e) nm1054 mouse skin from the nose. Blue staining indicates Acbp
expression in the epidermis, hair follicles, and sebocytes. Original
magnification  20.
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levels of most of the major classes of polar and non-polar hair
lipids from wild-type, nm1054, and BAC 486B9 transgenic
nm1054 mice (Figure 5a, and Figures S1 and S2; data not
shown). However, we reproducibly observed a band unique
to nm1054 hair and a species present in all three genotypes
that was reduced in relative intensity in the nm1054 mutant
(Figure 5a). Based on the similar migration of the common
and unique bands, we inferred that these were likely
structurally related lipids and attempted to identify both
using an extensive battery of methods. The band unique to
nm1054 did not give strong ions in mass spectrometry, and
we were unable to obtain sufficient amounts to obtain a
coherent nuclear magnetic resonance spectrum (data not
shown). Consequently, we were unable to identify its
structure. However, commensurate with its co-migration
with the triacylglycerol standard tristearin (Figure 5a),
positive mode mass spectrometry in the presence of lithium
revealed that the common band represents triacylglycerols,
with the strongest ion of m/z 865.7 corresponding to the
expected mass of a lithium adduct of a triacylglycerol with a
total fatty acyl chain length of C52 and two unsaturations
(Figure 5b). Collision-induced mass spectrometry identified
ions corresponding to products derived from the loss of C18:1
and C16:0 fatty acyl chains, confirming the identity of this
lipid (Figure 5c). Overall, these data indicate that nm1054
mice produce sebaceous lipids with reduced levels of
triacylglycerols accompanied by the appearance of an
unidentified, nearly co-migrating lipid.
DISCUSSION
In this study, we have uncovered an important role for the
Acbp in mouse hair and skin. We have demonstrated that the
gene encoding Acbp is expressed at high levels in the PSUs of
mouse skin and that loss of Acbp is responsible for the
abnormal cutaneous phenotype of nm1054 mice. Consistent
with the reported role of Acbp in lipid metabolism and its
preferential role in synthesis of neutral glycerolipids, we
identified a selective abnormality in triacylglycerols present
on nm1054 hair.
Acbp joins a growing list of fatty acid metabolism genes in
which mutations result in selective or predominant cutaneous
phenotypes. Among these proteins is fatty acid transport
protein 4 (Fatp4), which functions as an acyl-CoA synthetase
and plays an important role in uptake and metabolism of long
and very long-chain fatty acids (Hirsch et al., 1998; Stahl
et al., 1999; Hall et al., 2005). Loss of fatty acid transport
protein 4 results in neonatal lethality owing to restrictive
dermopathy, a condition characterized by abnormally thin
and tight skin with an expanded epidermis, a restricted
dermis, and a reduced number of PSUs (Herrmann et al.,
2003; Moulson et al., 2003). Similarly, Elovl3 belongs to a
family of enzymes involved in the biosynthesis of very long-
chain fatty acids (Tvrdik et al., 2000) and is expressed
primarily in the sebaceous glands and hair follicles of the skin
(Westerberg et al., 2004). Mice deficient for Elovl3 have
sparse fur, an expanded epidermis, and enlarged sebocytes
(Westerberg et al., 2004). Loss of the gene encoding the acyl-
CoA:diacylglycerol acyltransferase, a key enzyme in diacyl-
glycerol synthesis, results in sparse, dry hair, and a decreased
number of sebocytes (Chen et al., 2002). Mice lacking
stearoyl-CoA desaturase, which is involved in monounsatu-
rated fatty acid biosynthesis, have atrophic sebocytes and a
decreased level of triglycerides and cholesterol esters in the
skin (Miyazaki et al., 2001). Finally, sparse hair and cyst-like
inclusions in the skin of scraggly mice result from an
abnormal lipid distribution in the hair and skin (Herron
et al., 1999). These studies, along with our own, indicate that
proper fatty acid metabolism is critical for normal hair and
skin development and maintenance.
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Figure 5. Chromatographic analysis of hair lipids. (a) Preparative silica TLC
of lipids extracted from wild-type, BAC 486B9 transgenic nm1054, and
nm1054 hair showing a lower intensity band (closed arrowhead) in the
nm1054 hair nearly co-migrating with a triacylglycerol standard (tristearin), as
well as a unique band (open arrowhead) not present in wild-type or transgenic
mutant hair. (b) Positive mode mass spectrometric analysis with lithium of
nm1054 hair lipids indicated by the closed arrow in (a), yielding ions of m/z
839.8, 865.7, and 891.8. The ion at m/z 865.7 corresponds to the expected
mass of a lithium adduct of a triacylglycerol. (c) Collision-induced mass
spectrometry spectrum of the ion at m/z 865.7 shows product ions
corresponding to lithium adducts of diacylglycerol units after the loss of
C18:1 (m/z 583.7) and C16:0 (m/z 609.4), confirming the initial structure of
a triacylglycerol with two C18:1 and one C16:0 fatty acyl units (inset).
The positions of fatty acids and unsaturations are shown arbitrarily.
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Acbp is thought to bind medium- and long-chain fatty
acyl-CoA esters and donate them for use in other processes,
including triacylglycerol biosynthesis (Rasmussen et al.,
1993, 1994). TLC analysis shows that nm1054 hair has a
relative decrease in triacylglycerols and an accompanying
increase in a novel, closely migrating band that may
represent a related lipid, suggesting a defect in triacylglycerol
metabolism. Despite extensive characterization, we were
unable to identify the novel lipid under conditions where
common lipids were readily detected (Figure 5b; data not
shown).
The increase in sebocytes and the altered lipid profile
undoubtedly contribute to the matted, greasy appearance of
the adult coat. It is possible that the sebocyte hyperplasia
itself is due to an increase in peroxisome proliferator-
activated receptor (PPAR)-mediated gene transcription. The
PPARs are nuclear hormone receptors that are activated by
binding to fatty acids (Forman et al., 1997; Kliewer et al.,
1997; Krey et al., 1997) and regulate transcription of a
plethora of genes involved in lipid metabolism (Gervois et al.,
2000; Smith, 2002; Kota et al., 2005) and skin development
(Rosenfield et al., 2000; Di-Poi et al., 2004). Loss of the gene
encoding the PPARg subtype is embryonic lethal (Rosen
et al., 1999). However, analysis of chimeric PPARg null mice
showed that PPARg is required for sebocyte differentiation.
Furthermore, expression of PPARg in cultured cells promotes
sebocyte maturation, lipid accumulation, and triacylglycerol
synthesis (Rosenfield et al., 1999; Schadinger et al., 2005).
Consistent with the role of PPARg in sebocyte differentia-
tion, PPARg and Acbp may function interdependently in fatty
acid metabolism. Acbp and PPARg are both expressed in the
epidermis, hair follicles, and sebocytes of mouse skin
(Figure 4; Rosenfield et al., 2000; Di-Poi et al., 2004), and
these cell lineages share a common origin and can affect
differentiation and function of one another (Reynolds and
Jahoda, 1992; Ferraris et al., 1997; Taylor et al., 2000;
Oshima et al., 2001). Acbp is upregulated by PPARg and is
thought to compete for binding to fatty acids that stimulate
PPARg-dependent transcription (Helledie et al., 2000,
2002a). The processes of fatty acid conversion to CoA esters
and reversion back to free fatty acids are in constant
equilibrium, with CoA esters preferentially binding Acbp
and free fatty acids binding PPARg (Hertz et al., 1994; Hunt
et al., 1999; Helledie et al., 2002b). An increase in Acbp
expression or an increase in the level of fatty acyl-CoA esters
decreases PPARg-mediated transcription, presumably by
reducing the level of free fatty acids available for binding to
PPARg (Helledie et al., 2000, 2002a). Therefore, in the
absence of Acbp, fatty acids may be in excess and available
to stimulate PPARg-mediated transcription, which could
eventuate into sebocyte hyperplasia and alterations in hair
lipid composition. Alternatively, it is entirely possible that
changes in triacylglycerol metabolism may regulate tran-
scription of other signals in a PPAR-independent manner.
Although Acbp is expressed in all tissues, we did not
detect morphological or lipid abnormalities in any tissue
other than hair or skin. To this end, there may be proteins
functionally redundant with Acbp, and expression of these
molecules may vary in different tissues. This possibility could
also explain the difference between yeast with a targeted
deletion of the Acbp ortholog, where there is a dramatic
increase in long-chain fatty acyl-CoA esters (Schjerling et al.,
1996), and nm1054 mouse hair, where the vast majority of
lipids are synthesized at normal levels and have correct fatty
acyl chain lengths. Alternatively, it is possible that loss of
Acbp produces a cell-autonomous defect in mouse skin,
whereas other tissues may compensate for a loss of Acbp by
taking up lipids or other molecules produced elsewhere
through redundant pathways. Such molecules may not be in
sufficient supply in skin, necessitating the requirement for
endogenous Acbp. This hypothesis could explain the
apparently paradoxical findings that Acbp is essential in cell
culture (Faergeman and Knudsen, 2002) and the whole
animal lacking the gene survives.
At the present time, no human disorders have been
described that resemble the hair and skin phenotype seen in
nm1054 mice, and no related lipid metabolism disorders
have been mapped near ACBP. However, an increased
understanding of the role of Acbp in cutaneous development
and maintenance could play a pivotal role in future studies of
human skin disease pathophysiology and therapy.
MATERIALS AND METHODS
Mice
The nm1054 mutation was maintained on both the C57BL/6J (B6)
and the 129S6/SvEvTac (129) backgrounds as described previously
(Ohgami et al., 2005a). All phenotypic analysis was performed on
B6129F1 males at 8 or 24 weeks. All animal procedures were
approved by the Animal Care and Use Committee at Children’s
Hospital Boston.
Transgenic rescue
BAC transgenic animals were generated as described previously
(Ohgami et al., 2005b). Transgenic mice were identified by BAC
end-specific PCR, as well as internal polymorphisms between the
129X1/SvJ transgene and the C57BL/6 background.
Histological analysis
Eight- and 24-week-old mice were killed, and the entire pelt and the
ears were fixed in 10% buffered formalin. After 24 hours, the nose
and standardized sections of skin from the lower thorax were
transferred to 70% ethanol. Paws and tails were fixed in Bouin’s
fixative, until the bones were fully decalcified. All tissues were
embedded in paraffin, sectioned, and stained with hematoxylin and
eosin.
Northern analysis
A 32P-labeled Acbp probe was generated by PCR amplification of the
open reading frame from expressed sequence tag clone BQ947297
(Invitrogen, Carlsbad, CA), which contains full-length Acbp, using
primers 50-CCTCAAGACTCAGCCAACTG-30 and 50-GACTCGTG
GAACAAGCTGAA-30. A multi-tissue mouse Northern blot (OriGene
Technologies Inc., Rockville, MD) was prehybridized in MiracleHyb
solution (Stratagene, La Jolla, CA) for 30 minutes at 651C and
hybridized in the same solution with the Acbp probe. The blot was
washed twice with 2 SSC/0.1% SDS and then twice with
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0.2 SSC/0.1% SDS, all at 651C. Expression was detected by
autoradiography.
In situ hybridization
Ten micrograms of expressed sequence tag clone BQ947297
(Invitrogen, Carlsbad, CA) was digested with SalI and HindIII to
generate antisense and sense probes, respectively. Riboprobes were
labeled using a digoxigenin RNA labeling kit (Roche Molecular
Biochemicals, Indianapolis, IN). Automated in situ hybridization
was performed on the Ventana Discovery System (Ventana Medical
Systems, Tucson, AZ). Wild-type and nm1054 skin were fixed in 4%
paraformaldehyde and embedded in paraffin. Deparaffinized sec-
tions were digested with proteinase K at 371C, hybridized at 651C for
6 hours, and washed twice in 0.1 SSC at 751C. The digoxigenin
label was detected with a biotinylated anti-digoxigenin antibody
(Biogenex, San Ramon, CA), followed by a streptavidin–alkaline
phosphatase conjugate, and visualized by an nitroblue tetrazolium/
5-bromo-4-chloro-3-indolyl phosphate substrate reaction with
the BlueMap Detection Kit (Ventana Medical Systems, Tucson,
AZ). Slides were counterstained with nuclear fast red (Vector
Laboratories Inc., Burlingame, CA), dehydrated, and analyzed by
light microscopy.
Reverse transcription-PCR
RNA was isolated from mouse thymus using the RNAqueous kit
(Ambion, Austin, TX). RNA (0.5 mg) was primed with an oligo-dT
primer and reverse-transcribed using the SuperScript first-strand
synthesis kit (Invitrogen, Carlsbad, CA). BAB29121 was amplified
from reverse transcribed cDNA using primers 50-CTCATCCGTTC
ATTTGAGCA-30 and 50-CAGGACGAGATGGGATTAGC-30. Ampli-
fication products were visualized by agarose gel electrophoresis.
Lipid isolation
Lipids were derived from plucked fur, sections of shaved skin, and
sections of liver from 8- or 24-week-old male mice fasted for 4 hours.
Lipids were extracted serially with choloform:methanol 2:1 (v/v),
chloroform:methanol 1:1, and chloroform:methanol 1:2, each for
1 hour at room temperature. After each extraction, the samples were
centrifuged at 2,000 g for 5 minutes. The supernatants containing
the lipids were pooled, evaporated under a nitrogen stream, and
solvated in cholorform.
Thin-layer chromatography
Polar and non-polar lipids were separated by TLC using silica plates
(Scientific Adsorbents Inc., Atlanta, GA). Equal amounts of lipids
extracted from plucked hair, skin, or liver of wild-type, nm1054, and
BAC 486B9 transgenic nm1054 mice were spotted onto TLC plates.
For polar lipids, plates were developed with chloroform:methanol:-
water 60:35:5 (v/v/v). Non-polar lipids were separated and analyzed
as described previously (Downing, 1968). Briefly, after development
with hexane to the top of the plate, the plate was dried, redeveloped
to the same point with benzene, dried, and developed again with
hexane:diethyl ether:acetic acid 70:30:1 (v/v/v) to the midpoint of
the plate. TLC bands were visualized either by spraying the plate
with 3% cupric acetate (w/v) in 8% phosphoric acid (v/v), followed
by charring at 1801C, or by a non-destructive method modified by
Plekhanov (1999). Briefly, the plate was sprayed with 1 M ammo-
nium acetate and then submerged in a 1 M ammonium acetate
solution saturated with naphthol blue black (Sigma-Aldrich, St Louis,
MO) and dried. Bands were scraped and extracted three times with
5 ml chloroform:methanol 2:1 (v/v).
HPLC – mass spectrometry
Equal amounts of polar lipids were separated by HPLC – mass
spectrometry using a method modified by Matsunaga et al. (2004). A
Monochrome Diol column was coupled online to an LCQ
Advantage ion-trap mass spectrometer equipped with an electro-
spray ionization source. Mobile phase A was hexane:isopropanol
60:40 (v/v) containing 0.1% formic acid, 0.05% ammonium
hydroxide, and 0.05% triethylamine. Mobile phase B was methanol
containing 0.1% formic acid, 0.05% ammonium hydroxide, and
0.05% triethylamine. Using a flow rate of 0.7 ml/minute, a binary
gradient started at 5% mobile phase B (B), increased linearly to 15%
B in 6 minutes, held for 10 minutes, increased linearly to 100% B in
12 minutes, held for 6 minutes, and returned to 5% B in 2 minutes.
Eluants were analyzed by UV absorbance and direct online mass
spectrometry.
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